Evidence map›Paper›PMID 37945032›Full record

Observational studyThe European respiratory journal2023

Asthma and incident coronary heart disease: an observational and Mendelian randomisation study.

Carlos A Valencia-Hernández, Fabiola Del Greco M, Varun Sundaram, Laura Portas, Cosetta Minelli, Chloe I Bloom

Erratum issuedOpen access · hybridAbstract readObservational Study
In one paragraph

Observational study in The European respiratory journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Association between asthma and cardiovascular disease among a United States representative population.International journal of cardiology. Cardiovascular risk and prevention · 2025
    Article
  6. Article
  7. Connecting the Dots: How MicroRNAs Link Asthma and Atherosclerosis.International journal of molecular sciences · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Systemic Inflammation in Asthma: What Are the Risks and Impacts Outside the Airway?The journal of allergy and clinical immunology. In practice · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

Carlos A Valencia-HernándezNational Heart and Lung Institute, Imperial College London, London, UK.ORCID 0000-0002-7596-4846
Fabiola Del Greco MInstitute for Biomedicine, Eurac Research, Bolzano, Italy.
Varun SundaramLouis Stokes Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Laura PortasNational Heart and Lung Institute, Imperial College London, London, UK.
Cosetta MinelliNational Heart and Lung Institute, Imperial College London, London, UK.ORCID 0000-0001-9166-3958
Chloe I BloomNational Heart and Lung Institute, Imperial College London, London, UK chloe.bloom06@imperial.ac.uk.ORCID 0000-0003-1285-7602
Imperial College London · GBEurac Research · ITLouis Stokes Cleveland VA Medical Center · USLung Institute · USOpen Data Institute · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundObservational studies suggest asthma is a risk factor for coronary heart disease (CHD) and sex modifies the risk, but they may suffer from methodological limitations. To overcome these, we applied a "triangulation approach", where different methodologies, with different potential biases, were leveraged to enhance confidence in findings.

methodsFirst, we conducted an observational study using UK medical records to match asthma patients 1:1, by age, sex and general practitioner (GP) practice, to the general population. We measured the association between asthma and incident CHD (myocardial infarction: hospitalisation/death) by applying minimal sufficient adjustment: model 1, smoking, body mass index, oral corticosteroids, atopy and deprivation; model 2, additionally adjusting for healthcare behaviour (GP consultation frequency). Second, we conducted a Mendelian randomisation (MR) study using data from the UK Biobank, Trans-National Asthma Genetic Consortium (TAGC) and Coronary Artery Disease Genome-wide Replication and Meta-analysis consortium (CARDIoGRAM). Using 64 asthma single nucleotide polymorphisms, the effect of asthma on CHD was estimated with inverse variance-weighted meta-analysis and methods that adjust for pleiotropy.

resultsIn our observational study (n=1 522 910), we found asthma was associated with 6% increased risk of CHD (model 1: HR 1.06, 95% CI 1.01-1.13); after accounting for healthcare behaviour, we found no association (model 2: HR 0.99, 95% CI 0.94-1.05). Asthma severity did not modify the association, but sex did (females: HR 1.11, 95% CI 1.01-1.21; males: HR 0.91, 95% CI 0.84-0.98). Our MR study (n=589 875) found no association between asthma and CHD (OR 1.01, 95% CI 0.98-1.04) and no modification by sex.

conclusionsOur findings suggest that asthma is not a risk factor for CHD. Previous studies may have suffered from detection bias or residual confounding.

Indexed as

AsthmaCoronary Artery DiseaseMyocardial InfarctionAnalysis of VarianceFemaleGenome-Wide Association StudyHumansMaleMendelian Randomization AnalysisPolymorphism, Single NucleotideRisk Factors

Identifiers

PMID37945032
PMCPMC10695770
OpenAlexW4388524162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.